BioCatalyst

RSVpreF — catalyst calendar

2 verified catalyst event(s) referencing RSVpreF, each linked to its official source. Verified as of 2026-10-01.

Upcoming

DateEventCompanyDrugOfficial source & verification
2027-01-18
in 4mo
ESTIMATED
 READOUT
Study to Evaluate the Efficacy, Immunogenicity, and Safety of RSVpreF in Adults.
Phase 3 · Lower Respiratory Tract Illness
 PFE PFIZER INC RSVpreF ClinicalTrials.gov ↗
✓ Source-checked 2026-10-01
Sponsor-projected date — can change
2027-01-25
in 4mo
ESTIMATED
 READOUT
A Phase 3 Study in India to Describe the Safety and Immunogenicity of RSVpreF
Phase 3 · Respiratory Syncytial Virus (RSV)
 PFE PFIZER INC RSVpreF ClinicalTrials.gov ↗
✓ Source-checked 2026-10-01
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.